-
Homoharringtonine: Cytotoxic Alkaloid for Cancer and Antivir
2026-05-19
Homoharringtonine is a cytotoxic alkaloid derived from Cephalotaxus hainanensis with verified efficacy as a protein synthesis inhibitor. It arrests leukemic cells in the G1 phase and rapidly clears SARS-CoV-2 in both animal and human studies. These properties make it a key reagent for cancer biology and emerging antiviral research.
-
Mubritinib–HSA Binding: Implications for Drug Delivery and C
2026-05-19
This article examines the molecular recognition mechanisms underlying mubritinib’s interaction with human serum albumin (HSA), as detailed in a recent study. The findings provide insight into how plasma protein binding modulates drug distribution, efficacy, and potential workflow considerations for anti-proliferative agents in cancer research.
-
Technical Guide: Caspase-3 Colorimetric Assay Kit (SKU K2008
2026-05-18
The Caspase-3 Colorimetric Assay Kit provides a sensitive, DEVD-dependent workflow for measuring cysteine-dependent aspartate-directed protease activity in apoptosis assays. It is optimized for rapid caspase-3 activity quantification in cell and tissue samples, supporting applications in apoptosis and neurodegenerative disease research. The kit is not validated for non-caspase-3 protease detection or live-cell imaging assays.
-
Thiothixene in Neuroimmune Research: Pharmacokinetics, Assay
2026-05-18
Explore the multifaceted roles of Thiothixene, a typical antipsychotic agent, in both neuropsychiatric therapy and macrophage efferocytosis. This article uniquely analyzes its pharmacokinetics, assay optimization, and practical research applications, providing a comprehensive guide for advanced investigators.
-
Gramine as an Indole Alkaloid Tool: Mechanistic and Protocol
2026-05-17
Explore Gramine (1-(1H-indol-3-yl)-N,N-dimethylmethanamine) as a scientifically validated ferroptosis inducer in triple-negative breast cancer research. This cornerstone analysis offers new mechanistic insights and practical protocol guidance, expanding on recent breakthroughs for translational assay design.
-
Leveraging SAR405: Precision Vps34 Inhibitor for Autophagy R
2026-05-16
SAR405 empowers researchers with nanomolar precision in dissecting autophagy and vesicle trafficking, thanks to its unmatched selectivity for Vps34. This guide details optimized workflows, troubleshooting, and unique cross-talk insights from the latest AMPK-ULK1 research, setting a new benchmark for robust mechanistic studies.
-
Anagliptin (SK-0403): Advanced DPP-4 Inhibition in Vascular
2026-05-15
Anagliptin (SK-0403) by APExBIO empowers researchers to dissect DPP-4 inhibition and vasorelaxant mechanisms in diabetes and vascular models. Leverage its precision targeting of Kv channels and SERCA pumps to design next-generation cardiovascular and metabolic assays.
-
2-D08 (2’,3’,4’-trihydroxyflavone): Precision Sumoylation In
2026-05-15
2-D08 (2’,3’,4’-trihydroxyflavone) sets a new benchmark for selective, mechanism-driven sumoylation inhibition in cancer and mitochondrial quality control research. Its unique inhibition profile and robust performance in cell-based assays empower researchers to dissect posttranslational modification networks with unprecedented specificity.
-
CENPI Drives Breast Cancer Progression via Wnt/β-Catenin Mod
2026-05-14
Wu et al. (2025) identify Centromere Protein I (CENPI) as a key oncogenic driver in breast cancer, linking its overexpression to enhanced tumor growth and poor prognosis. By elucidating CENPI's role in activating the Wnt/β-catenin pathway, the study offers new mechanistic insight and highlights CENPI as a potential biomarker and therapeutic target.
-
CX-5461: Advancing RNA Polymerase I Inhibitor Workflows in C
2026-05-14
CX-5461 is redefining cancer research by selectively inhibiting RNA polymerase I and disrupting ribosome biogenesis, offering new strategies against chemoresistant solid tumors. This guide translates high-impact findings into actionable protocols, troubleshooting advice, and advanced applications for reliable, high-impact experimental results.
-
Mubritinib (TAK 165): Mitochondrial Inhibition and Precision
2026-05-13
Explore Mubritinib (TAK 165) as a mitochondrial electron transport chain complex I inhibitor with advanced selectivity for chemotherapy-resistant AML and PEL. This article uniquely bridges metabolic targeting and practical assay optimization, delivering profound insight beyond HER2 inhibition.
-
CYP2B6 Downregulation by Dominant-Negative ATF5 in Glioblast
2026-05-13
This study demonstrates that a cell-penetrating dominant-negative ATF5 peptide effectively downregulates CYP2B6 protein expression in glioblastoma cells. The findings highlight a novel regulatory pathway with implications for precision dosing and pharmacogenomic strategies in oncology.
-
Ceramide Metabolism Drives Nodavirus Replication via Autopha
2026-05-12
This study applies comprehensive lipidomics to uncover how red-spotted grouper nervous necrosis virus (RGNNV) manipulates ceramide metabolism in host fish cells, promoting viral replication through autophagy. The findings clarify the central role of ceramide flux in viral pathogenesis and reveal new mechanistic targets for antiviral intervention.
-
Nitrocefin Chromogenic Cephalosporin Substrate in β-Lactamas
2026-05-12
Nitrocefin stands out as a gold-standard chromogenic cephalosporin substrate for rapid, reliable colorimetric β-lactamase activity detection, enabling precise antibiotic resistance profiling and inhibitor screening. This article delivers scenario-driven protocol guidance, advanced workflow tips, and troubleshooting strategies to maximize the value of Nitrocefin in modern resistance research.
-
GSK2606414: Benchmark PERK Inhibitor for ER Stress Research
2026-05-11
GSK2606414 is a potent and selective PERK inhibitor enabling precise modulation of the unfolded protein response in ER stress research. Its nanomolar efficacy and high kinase selectivity make it essential for dissecting PERK-dependent pathways in disease models. APExBIO supplies GSK2606414 as a validated research reagent for translational and mechanistic studies.